scispace - formally typeset
Open AccessJournal ArticleDOI

Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis

TLDR
This study shows that persistent renal insufficiency associated with macroscopic atrophy and microscopic fibrosis is not so rare in IgG4-related TIN, and the behavior of regulatory T cells during the clinical course is quite similar to that of IgG 4-positive plasma cells.
Abstract
Objectives This study aimed to investigate the clinicopathological changes induced by corticosteroid therapy in immunoglobulin (Ig)G4-related tubulointerstitial nephritis (TIN).

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

IgG4-related kidney disease.

TL;DR: Tubulointerstitial nephritis with increased IgG4-positive plasma cells and fibrosis is the most dominant feature of IgG 4-RKD and may cause acute or chronic renal dysfunction, although some glomerular lesions such as membranous nephropathy are sometimes evident.
Journal ArticleDOI

The clinical course of patients with IgG4-related kidney disease.

TL;DR: The response of IgG4-related kidney disease to corticosteroids is rapid, not total, and the recovery of renal function persists for a relatively long time under low-dose maintenance, suggesting a large-scale prospective study to formulate more useful treatment strategies is necessary.
Journal ArticleDOI

Characteristic tubulointerstitial nephritis in IgG4-related disease.

TL;DR: The distinctive histologic features of IgG4-related tubuloInterstitial nephritis can facilitate the differential diagnosis of tubulointerstitial nephitis, even without autoimmune pancreatitis or an abnormal computed tomography suggesting a renal tumor.
Journal ArticleDOI

IgG4-related disease and the kidney

TL;DR: This Review, it is summarized current knowledge of IgG4-RD and its most frequent manifestations in the kidney—IgG 4-related tubulointerstitial nephritis (TIN) and membranous glomerulonephropathy (MGN).
Journal ArticleDOI

IgG4-related disease: a clinical perspective.

TL;DR: The first-line treatment of IgG4-RD is based on glucocorticoids, which are usually efficacious, but B cell depletion induced by rituximab has also been found to induce remission in steroid-resistant disease or has been used as steroid-sparing agent for relapsing disease.
References
More filters
Journal ArticleDOI

High serum IgG4 concentrations in patients with sclerosing pancreatitis.

TL;DR: Patients with sclerosing pancreatitis have high serum IgG4 concentrations, providing a useful means of distinguishing this disorder from other diseases of the pancreas or biliary tract.
Journal ArticleDOI

Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

TL;DR: AIPC is a unique inflammatory disorder characterized by an immune reaction predominantly mediated by Th2 cells and Tregs, which could be characterized by the over‐production of T helper (Th) 2 and regulatory cytokines.
Journal ArticleDOI

Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis

TL;DR: In this article, the ureteral and pancreatic lesions of 22 patients with sclerosing pancreatitis were histologically examined and found abundant infiltration of lgG4-bearing plasma cells in both tissues.
Journal ArticleDOI

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

TL;DR: Treatment with rituximab led to prompt clinical and serologic improvement in these patients with refractory IgG4-RSD, and is a viable treatment option for this condition, suggesting that ritUXimab achieves its effects in IgG 4- RSD by depleting the pool of B lymphocytes that replenish short-lived IgG3-secreting plasma cells.
Related Papers (5)